Please visit the Vaccine Education Center for general information about HPV and the vaccine.
HPV is the most common sexually transmitted infection around the world. Each year, about 300,000 women die worldwide from cervical cancer.
In the U.S. each year, about 6 million people are infected with HPV, 10,000 women develop cervical cancer and 4,000 women die from cervical cancer. There are currently about 20 million Americans living with HPV.
Human papillomavirus (HPV) and the HPV vaccine made headlines recently. Misinformation about the disease and the vaccine may lead to decisions to forego vaccination. In fact, a recent survey of adolescent girls suggested that many are not being immunized with this important vaccine. In the light of these events, we felt it was important to provide accurate information.
HPV is a family of viruses, some of which cause:
HPV is transmitted by sexual contact, most often in the form of sexual intercourse. However, it can also be transmitted by genital-to-genital contact and oral sex.
HPV infections are unique. First, most people never know they were infected. Unlike a cold in which symptoms develop a few days after exposure to the virus, HPV infections are typically not symptomatic. Second, HPV infections can last for long periods of time. The average length of infection is about eight months; however, for about 1 of every 10 women, the infection lasts longer than two years. It is in this group of women that there is an increased risk of developing cervical cancer. Cervical cancer often doesn’t occur until years after the initial infection.
The risk of contracting HPV can be reduced or prevented by:
The HPV vaccine is recommended for girls between 11 and 12 years of age; however, those as young as 9 and women as old as 26 can also be immunized. Girls can get either version of the vaccine. Boys between the ages of 9 and 18 years of age can also get the HPV vaccine; however, only the Gardasil® vaccine, that contains four types of HPV, is licensed for use in boys.
Some parents do not want to give HPV vaccine to their adolescents because they are not yet sexually active and parents do not want to promote sexual activity; however, the vaccine will work best when given before any sexual activity, even if that activity occurs years later. Unfortunately, half of new infections each year are in teens and young adults between 15 and 24 years old. And studies have shown that HPV vaccine does not increase the likelihood of indiscriminate sexual activity.
HPV vaccines have been given to millions of people. Of those who got the vaccine, the most common adverse events were pain, redness or swelling at the injection site. Fainting has also been associated with the vaccine; therefore, patients should stay seated or lying down for about 15 minutes after getting the vaccine.
During a recent presidential primary debate, one candidate suggested that the vaccine can cause mental retardation; however, this condition has never been associated with the HPV vaccine nor does the timing make sense, since mental retardation is typically diagnosed in early childhood and the vaccine is given in adolescence.
Some parents have claimed that the vaccine caused blood clots, strokes or heart attacks. However, when these claims were investigated, no association was found. In most cases, use of birth control pills was linked to these outcomes.
Updated: January 2012
We would like to hear from you, please use our online form to contact us with questions or comments.